The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toripalimab with Fruquintinib as the third-line treatment for refractory advanced metastatic colorectal cancer: Results of a single-arm, single-center, prospective, phase II clinical study.
 
Shoucheng Ma
No Relationships to Disclose
 
Rui Chen
No Relationships to Disclose
 
Xiaoming Hou
No Relationships to Disclose
 
Lin Duan
No Relationships to Disclose
 
Chunmei Li
No Relationships to Disclose
 
Tianning Yang
No Relationships to Disclose
 
Xiaoling Ling
No Relationships to Disclose
 
Da Zhao
No Relationships to Disclose